Future Tech: Almost Here, Round-the-corner Future Technology Podcast

Paul Turner & Robert McBride, co-founders of Felix Biotechnology (felixbt.com), discuss the growing problem of antibiotic resistance and the new therapies on the horizon. In this podcast they’ll discuss: * The ways in which targeted biotherapeutics could change modern medicine * What regulatory hurdles do biotech companies face as they march to the marketplace? * Just how bad is the antibiotic resistance problem globally? Turner & McBride’s biotech company, Felix Biotechnology, is heavily focused on progressing the deployment of novel biotherapeutics that can target urgent microbial challenges within human health, and much more. Turner & McBride discuss the greatest challenges they face in the biomedical field, including the widespread failure of traditional antibiotics. They discuss some of the older technologies they are in the process of updating, such as developing viruses that specifically kill bacteria. Turner & McBride believe that this option will give the medical commun